Skip to content

Clinical trials

Completed Phase 1 Bronchiolitis Obliterans Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 1 Status: Completed Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20072
20082
20092
20102
20113
20122
20132
20153
20171
20181
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche4
Amgen2
Dana-Farber Cancer Institute2
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)1
Bristol-Myers Squibb1
Children's Hospital Medical Center, Cincinnati1
Emory University1
Genentech, Inc.1
GlaxoSmithKline1
Gruppo Italiano Trapianto di Midollo Osseo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome25
Hepatitis C4
Leukemia4
Lymphoma4
Graft vs Host Disease3
Neoplasms3
Leukemia, Lymphoid2
Lymphoma, Follicular2
Lymphoma, Large B-Cell, Diffuse2
Multiple Myeloma2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.